on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Schedules Investor Webcast for Q1 2025 Financials
Jaguar Health, Inc. (NASDAQ: JAGX) has announced an investor webcast scheduled for May 15, 2025, at 4:15 PM Eastern Time. This event will focus on the company's first-quarter 2025 financial results and recent corporate updates. The webcast provides an opportunity for stakeholders to understand Jaguar Health's performance and future trajectory.
The company plans to publish its earnings report on Form 10-Q on the same day, covering the quarter that ended on March 31, 2025. Interested participants are encouraged to register through the provided link.
Jaguar Health, a commercial-stage pharmaceuticals company, specializes in developing proprietary medicines from plants. Their scope includes treatments for human and animal gastrointestinal issues, with a notable focus on overactive bowel conditions.
Subsidiary Napo Pharmaceuticals focuses on human prescription drugs, while Napo Therapeutics aims to expand access to crofelemer in Europe. Additionally, Jaguar's joint venture, Magdalena Biosciences, targets novel treatments for mental health.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news